Stopping GLP-1 weight loss and diabetes drugs for just six months can quickly erase any related benefits for cardiovascular health, researchers have said.
A three-year study by Washington University in St. Louis included more than 333,000 U.S. veterans with type 2 diabetes taking the drugs showed that halting or interrupting treatment was linked to a significant increase in the risk of major cardiovascular events.